UnitedHealth (UNH) surged 7% pre-market after beating Q1 earnings and raising FY2026 guidance to over $18.25. Improved margins, with a medical cost ratio of 83.9%, and a $2 billion buyback fuelled the rally. Investors cheered the strong outlook, with retail sentiment projecting over 40% upside.